Legal & General Group PLC Innoviva, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 185,025 shares of INVA stock, worth $3.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185,025
Previous 185,025 -0.0%
Holding current value
$3.32 Million
Previous $3.57 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$16.33 - $20.04 $298,806 - $366,691
18,298 Added 10.97%
185,025 $3.57 Million
Q2 2024

Aug 14, 2024
BUY
$14.4 - $16.4 $42,984 - $48,953
2,985 Added 1.82%
166,727 $2.73 Million
Q1 2024

May 14, 2024
BUY
$14.56 - $16.78 $2,868 - $3,305
197 Added 0.12%
163,742 $2.5 Million
Q4 2023

Feb 15, 2024
SELL
$12.32 - $16.27 $42,257 - $55,806
-3,430 Reduced 2.05%
163,545 $2.62 Million
Q3 2023

Nov 14, 2023
SELL
$12.37 - $13.89 $109,016 - $122,412
-8,813 Reduced 5.01%
166,975 $2.17 Million
Q2 2023

Aug 14, 2023
SELL
$11.39 - $13.72 $74,798 - $90,099
-6,567 Reduced 3.6%
175,788 $2.24 Million
Q1 2023

May 15, 2023
SELL
$10.73 - $13.6 $14,893 - $18,876
-1,388 Reduced 0.76%
182,355 $2.05 Million
Q4 2022

Feb 14, 2023
BUY
$11.8 - $13.78 $5,569 - $6,504
472 Added 0.26%
183,743 $2.43 Million
Q3 2022

Nov 14, 2022
SELL
$11.61 - $15.22 $77,485 - $101,578
-6,674 Reduced 3.51%
183,271 $2.13 Million
Q2 2022

Aug 22, 2022
BUY
$14.32 - $19.88 $51,308 - $71,230
3,583 Added 1.92%
189,945 $2.8 Million
Q1 2022

May 16, 2022
SELL
$15.39 - $20.25 $21,207 - $27,904
-1,378 Reduced 0.73%
186,362 $3.61 Million
Q4 2021

Feb 14, 2022
BUY
$15.91 - $18.72 $67,887 - $79,878
4,267 Added 2.33%
187,740 $3.24 Million
Q3 2021

Nov 15, 2021
BUY
$13.06 - $17.24 $144,717 - $191,036
11,081 Added 6.43%
183,473 $3.07 Million
Q2 2021

Aug 12, 2021
SELL
$11.45 - $13.96 $504,303 - $614,854
-44,044 Reduced 20.35%
172,392 $2.31 Million
Q1 2021

May 17, 2021
BUY
$11.06 - $12.87 $24,497 - $28,507
2,215 Added 1.03%
216,436 $2.59 Million
Q4 2020

Feb 12, 2021
SELL
$9.33 - $12.48 $1,511 - $2,021
-162 Reduced 0.08%
214,221 $2.66 Million
Q3 2020

Nov 13, 2020
SELL
$10.33 - $14.49 $104,394 - $146,435
-10,106 Reduced 4.5%
214,383 $2.24 Million
Q2 2020

Aug 14, 2020
BUY
$11.49 - $15.26 $161,112 - $213,975
14,022 Added 6.66%
224,489 $3.14 Million
Q1 2020

May 14, 2020
BUY
$8.11 - $15.23 $2,132 - $4,005
263 Added 0.13%
210,467 $2.48 Million
Q4 2019

Feb 13, 2020
BUY
$10.28 - $14.38 $285,969 - $400,022
27,818 Added 15.25%
210,204 $2.98 Million
Q3 2019

Nov 13, 2019
BUY
$10.05 - $14.55 $93,816 - $135,824
9,335 Added 5.39%
182,386 $1.92 Million
Q2 2019

Aug 14, 2019
SELL
$13.1 - $14.95 $15,720 - $17,940
-1,200 Reduced 0.69%
173,051 $2.52 Million
Q1 2019

May 15, 2019
BUY
$13.69 - $20.06 $217,903 - $319,295
15,917 Added 10.05%
174,251 $2.45 Million
Q4 2018

Feb 15, 2019
SELL
$13.96 - $18.26 $7,789 - $10,189
-558 Reduced 0.35%
158,334 $2.75 Million
Q3 2018

Nov 20, 2018
BUY
$13.63 - $15.7 $123,487 - $142,242
9,060 Added 6.05%
158,892 $2.43 Million
Q2 2018

Aug 10, 2018
BUY
$13.44 - $17.59 $79,860 - $104,519
5,942 Added 4.13%
149,832 $2.07 Million
Q1 2018

May 17, 2018
SELL
$13.8 - $16.99 $62,638 - $77,117
-4,539 Reduced 3.06%
143,890 $2.41 Million
Q4 2017

Feb 13, 2018
BUY
$11.73 - $14.75 $1.74 Million - $2.19 Million
148,429
148,429 $2.11 Million

Others Institutions Holding INVA

# of Institutions
228
Shares Held
79.1M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.25B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email